Riaz Gillani, MD

Physician, Pediatric Hematology and Oncology
Assistant Professor of Pediatrics, Harvard Medical School
Riaz Gillani
Fax 617-632-4410
NPI 1902145949
Print Profile
Request an Appointment
Locations

Riaz Gillani, MD

Physician, Pediatric Hematology and Oncology
Assistant Professor of Pediatrics, Harvard Medical School

Medical Services

Programs & Services
Hematologic Malignancy Center
Solid Tumor Center
Cancer and Blood Disorders Center
Conditions & Treatments
Brain Tumors
Ewing Sarcoma
Leukemia
Neuroblastoma
Osteosarcoma
Soft Tissue Sarcomas
Languages
English
Hindi
Urdu
Education
Undergraduate School
Brown University
2009
Providence
RI
Medical School
Johns Hopkins University School of Medicine
2015
Baltimore
MD
Internship
Pediatrics
Boston Combined Residency Program (BCRP)
2016
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2018
Boston
MA
Fellowship
Pediatric Hematology and Oncology
Dana-Farber Cancer Institute/ Boston Children's Hospital
2021
Boston
MA
Professional History

Dr. Gillani uses computational techniques to understand the markers in cancer and normal patient genomes that are associated with the development and progression of disease, leveraging these insights to inform novel approaches to the treatment of pediatric cancer. He cares for patients with a range of solid tumor and hematologic malignancy diagnoses, with the overall aim of translating research insights to improved patient management.

Publications

Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group. View Abstract
Rare germline structural variants increase risk for pediatric solid tumors. View Abstract
Somatic structural variants drive distinct modes of oncogenesis in melanoma. View Abstract
Rare germline structural variants increase risk for pediatric solid tumors. View Abstract
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma. View Abstract
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. View Abstract
Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients. View Abstract
Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector. View Abstract
Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma. View Abstract
Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. View Abstract
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival. View Abstract
Hypotonia and Lethargy in a Two-Day-Old Male Infant. View Abstract
Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients. View Abstract
Case 1: Leg and Hip Pain in an 8-year-old Boy with Autism. View Abstract
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients. View Abstract
Nanofunctionalized zirconia and barium sulfate particles as bone cement additives. View Abstract
Locations